LIGAND PHARMAC.NEW DL-001 earnings per share and revenue

LGDN earnings per share for the last quarter are 1.65 EUR whereas the estimation was 1.21 EUR which accounts for 36.59% surprise. Company revenue for the same period amounts to 46.53 M EUR despite the estimated figure of 36.46 M EUR. Estimated earnings per share for the next quarter are 1.15 EUR, and revenue is expected to reach 37.70 M EUR. Also watch annual changes over time to get a bigger picture of LGDN earnings per share and revenue dynamics.